PEPTONIC medical

Sweden
Bromma, Sodermanlands Lan, Sweden, 167 51

Company profile

PEPTONIC medical company profile

PEPTONIC medical AB (publ), a pharmaceutical company, develops oxytocin based products for the treatment of menopausal symptoms. Its product includes Vagitocin, a developmental pharmaceutical preparation which is in Phase IIb study for the treatment of vaginal atrophy.

Business identity

Contact email
[email protected]
Phone number
+46 8 530 20 110
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2009-01-01

Headquarters

Postal code
167 51
Country code
SE
Continent
Europe

Capital profile

Funding and company signals

Funding stage
IPO
Funding rounds
5
Total equity funding
$5.1M
Last funding
Post IPO Equity / $1.1M / 2026-01-29
Last equity funding
Post IPO Equity / $1.1M
Investors
1
Articles
52
Exited on
2021-05-14

Founders and investors

Investors

Almi Invest